Sanofi (SNW BE) stock market data APIs
€83.37
0(0%)
as of July 2, 2025
Try our APIs with
free plan!
Sanofi Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for SNW.BE.
Prev. Close
83.37
Open
83.37
High
83.37
Low
83.37
52 wk Range
82.11-105.4891
Market Cap
108 619 M
EPS
1.79
Dividends (Yield)
0.0361
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Sanofi data using free add-ons & libraries
Get Sanofi Fundamental Data
Sanofi Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-04-24
- EPS/Forecast: 1.67
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Sanofi News
New
10 European Dividend Stocks That Could Beat Their U.S. Counterparts
European stocks are having a strong year. If the dollar continues to weaken, Europe may provide fertile hunting ground for dividend investors. Lower interest rates and proposals to increase defense spending have both contributed to U.S. stocks’ weak performance. Continue Reading View Comments
Sector Update: Health Care Stocks Lean Lower Premarket Tuesday
Health care stocks were leaning lower premarket Tuesday with the iShares Biotechnology ETF (IBB) and PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscri...
Adagene announces up to $25 million strategic investment from Sanofi
Adagene Inc. - Sanofi to exercise option on third SAFEbody discovery program and sponsor combination clinical trial with muzastotug - Company expects proceeds to extend cash runway into 2027 SAN DI...
Sanofi (ENXTPA:SAN) Gains Orphan Drug Status In Japan For CIDP Treatment
Sanofi recently received orphan drug designation from Japan's Ministry of Health for riliprubart, aimed at treating chronic inflammatory demyelinating polyneuropathy. This underscores the company's fo...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
